EIF2AK4 and acute promyelocytic leukemia: For example, GCN2 activation can be achieved with halofuginone, an alkaloid that binds to prolyl-tRNA synthetase to mimic the unavailability of proline [2], which has demonstrated anti-neoplastic properties against MM [89] and acute promyelocytic leukemia (APML) [90].